News & Articles
Selected Filters:
Siemens Healthineers announces FDA Emergency Use Authorization for rapid COVID-19 antigen self-test
Rapid antigen testing provides results in just 15 minutes and the information can help reduce the risk of COVID-19 exposure
Siemens Healthineers SARS-CoV-2 testing portfolio detects Omicron variant
The lab-based Atellica and ADVIA Centaur SARS-CoV-2 Antigen Assays (CoV2Ag) are well designed to detect Omicron variant
Siemens Healthineers now launching Sysmex CN-3000 and CN-6000 Hemostasis Systems
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
Siemens Healthineers AI-based COVID-19 severity algorithm now available
The company plans to interface the algorithm into the Atellica Data Manager software in the future
Siemens Healthineers has received CE Mark for the ACUSON AcuNav Volume ICE catheter
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
Siemens Healthineers lab-based antigen test available on high-throughput analyzers to support COVID-19 testing
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Siemens Healthineers is the first leading diagnostics company offering a quantitative COVID-19 test to measure neutralizing antibodies
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working
Siemens Healthineers launches rapid antigen test for the detection of SARS-CoV-2
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
Siemens collaborates with CDC to develop a novel process for standardizing SARS-CoV-2 assays
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
FDA clears AI-based MRI interpretation assistants from Siemens Healthineers
The AI-Rad Companion Brain MR and Prostate MR measures volumetric changes in brain, and segments prostate for targeted biopsy under MRI and ultrasound fusion imaging respectively
FDA clears Siemens Healthineers' bedside computed tomography scanner
The Somatom scanner is equipped with a forward-looking camera and motorized wheels, allowing a single technologist to navigate the device through hospital hallways
Siemens Healthineers obtains first FDA EUA for semi-quantitative antibody test
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
Siemens Healthineers and Geisinger announce value partnership to drive digital healthcare
The partnership aims to drive digital health collaborations, including artificial intelligence-enabled applications
Siemens Healthineers receives FDA emergency use authorization for SARS-CoV-2 total antibody test
Total antibody test aims to deliver superior clinical performance with 100% sensitivity and 99.8% specificity
Siemens Healthineers now shipping worldwide total antibody test and molecular test kit for COVID-19
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
Siemens Healthineers begins delivery of CE-IVD registered SARS-CoV-2 test kits
The molecular test kit promises 100% diagnostic sensitivity and specificity, and is authorized for clinical practice use in Europe
Siemens Healthineers to expand COVID-19 testing to include antibody test
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio
Siemens Healthineers receives FDA clearance to support COVID-19 response efforts
The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients
Siemens Healthineers adds fentanyl assay to its portfolio
New assay is designed to help laboratories address greater demand for opioid testing




















